help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kavelaars, A.
Right arrow Articles by Heijnen, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kavelaars, A.
Right arrow Articles by Heijnen, C. J.

Endocrinology, Vol 126, 3028-3032, Copyright © 1990 by Endocrine Society

ARTICLES

In vitro beta-adrenergic stimulation of lymphocytes induces the release of immunoreactive beta-endorphin

A Kavelaars, RE Ballieux and CJ Heijnen
Department of Pediatric Immunology, University Hospital for Children and Youth Het Wilhelmina Kinderziekenhuis, Utrecht, The Netherlands.

The immune system and the neuroendocrine system have been shown to be functionally interactive. The neuroendocrine system can modulate the immune response and immune mediators can influence the neuroendocrine system. The present paper focuses on the capacity of lymphocytes to produce and secrete neuroendocrine substances. Lymphocytes can secrete the neuropeptide beta-endorphin in response to activation with mitogen or antigen. Moreover, mediators that are involved in the adaptation to stress have also been shown to induce the release of immunoreactive- beta-endorphin by lymphocytes. It is shown here that stimulation of human peripheral blood mononuclear cells with the beta-adrenergic agonist isoprenaline induces beta-endorphin secretion. The effect of isoprenaline can be mimicked by elevation of the intracellular concentration of cAMP with forskolin or (Bu)2cAMP. Inhibition of cAMP- dependent protein kinase PKA by the antagonist N-[2-(methylamino)ethyl]- 5-isoquinoline-sulfonamide abrogates isoprenaline-induced secretion of immunoreactive-beta-endorphin by peripheral blood mononuclear cells. The present data give evidence that, beta-adrenergic activation activation of lymphocytes stimulates the secretion of ir-beta-endorphin via a protein kinase A-dependent mechanism. Both beta-adrenergic agonists as well as beta-endorphin have been shown to modulate the immune response. The data presented here are indicative for a role of beta-endorphin in the modulation of the immune response after beta- adrenergic activation.


This article has been cited by other articles:


Home page
 GutHome page
S Collins and M Verma-Gandhu
The putative role of endogenous and exogenous opiates in inflammatory bowel disease.
Gut, June 1, 2006; 55(6): 756 - 757.
[Full Text] [PDF]

Home page
 EndocrinologyHome page
S. A. Mousa, M. Shakibaei, N. Sitte, M. Schafer, and C. Stein
Subcellular Pathways of {beta}-Endorphin Synthesis, Processing, and Release from Immunocytes in Inflammatory Pain
Endocrinology, March 1, 2004; 145(3): 1331 - 1341.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society